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RNA silencing is a biochemical mechanism that regulates
gene expression by post-transcriptionally activating a
sequence-specific RNA degradation by three different
pathways: (i) small interfering RNA (siRNA) silencing of
exogenous mRNA; (ii) micro RNA (miRNA) silencing of
endogenous mRNAs, and (iii) associated with DNA
methylation and suppression of transcription [2].
These processes share three basic biochemical phases: (i)
formation of double-stranded (ds)RNA; (ii) processing of
dsRNA into small dsRNA molecules (sRNA); and (iii) tar-
geting of single-stranded small RNA to sequence-specific
DNA or RNA molecules. Although several mechanisms
can generate dsRNA, the sRNA processing and effector
phases have a common biochemical core.
One key-component of this system is small RNA mole-
cules of 21 to 26 nt called siRNAs (small interfering RNAs)
which originated from longer double-stranded RNA
(dsRNAs) cleaved by a specific RNase endonuclease called
DICER with distinctive dsRNA binding, RNA helicase,
RNase III and PAZ (Piwi/Argonaute/Zwille) domains. The
siRNA strands are further relaxed (unwound) and one
strand is incorporated in a RISC complex (RNA-induced
silencing complex) which contains a member of the Argo-
naute (Ago) protein family, guiding this complex to an
mRNA with a complementary sequence, which is then
cleaved, leading to gene silencing.
RNAi can be triggered by double-stranded or partially
self-complementary hairpin RNA formation. In addition to
playing a powerful role in creating loss of function muta-
tions in plants, RNAi biological functions include also the
regulation of endogenous gene expressions, such as micro
RNA (miRNA), heterochromatin formation, transposon
repression and defence against viral infection [2,3].
Several strategies have been employed for genetically
engineering resistance to viruses in transgenic plants,
including the expression of coat protein genes, the expres-
sion of truncated defective genes and antisense RNA. Now
that we better understand the mechanisms of RNA silen-
cing (RNAi) and its biological functions, it is possible to
look back on initial experiments from a new perspective.
It is now known that plants naturally process viral RNAs
to generate small sequences of a pathogen’s genetic mate-
rial that can be specifically used against that pathogen
through the RNA-induced silencing complex. It was
recognized that an RNAsilencing (post-transcriptional
gene silencing or PTGS) mechanism was responsible for
the resistance against RNA viruses, and that it depends on
the formation of double-strand RNA (dsRNA) whose anti-
sense strand is complementary to the transcript of a tar-
geted gene. This discovery led to the introduction in
transgenic plants of constructs to produce intracellular
generation of siRNA-like species to induce targeted gene
silencing and virus resistance.
RNA silencing has been an important tool to generate
plants resistant to a large range of viruses. RNA sense- or
antisense-mediated strategies resulted in a maximum
resistance frequency of 20%, but often far lower frequen-
cies were obtained. In addition, not all viral genes used in
transgenic constructs rendered resistant plants. The use of
inverted repeat constructs, resulting in dsRNA transcripts,
rendered a very efficient system in which much higher fre-
quency of transformed lines will display efficient gene
knockdown or virus resistance. The probable reason is
that the dsRNAs fed directly into the silencing pathway at
the level of the RNase III-like enzyme Dicer, and therefore
there is no reliance on the action of plant-encoded RNA-
dependent RNA polymerase proteins. So far, most exam-
ples of RNAi-mediated virus resistance are related to RNA
plant viruses.
Golden mosaic, caused by the Bean golden mosaic virus
(BGMV), transmitted by the whitefly Bemisia tabaci Gen.,
is one of the most limiting diseases for bean cultivation in
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the American continent. Since highly resistant bean vari-
eties are unavailable, control practices have focused on
controlling the vector with high-toxicity insecticides, with
cost-benefit ratio and environmental concerns. In Brazil,
the golden mosaic causes annual losses in bean production
ranging from 90,000 to 280,000 tons. In addition, there are
approximately 180,000 hectares unsuitable for bean crop-
ping in the dry season due to the high prevalence of
BGMV
The concept of using RNAi constructs was explored to
generate genetically modified (GM) bean lines resistant to
the BGMV by silencing the rep viral gene, which encodes
the only protein strictly essential for viral genome replica-
tion [4]. Two lines (named 2.3 and 5.1) showed immunity
to the BGMV upon inoculation at high pressure (>300 vir-
uliferous whiteflies per plant during its entire life cycle).
Under field conditions, no virus infection has been
observed in transgenic genotypes from 2007 to 2013, even
under high B. tabaci pressure (Aragão and Faria, 2009;
personal communication). In contrast, non-transgenic
varieties have shown up to 100% infection, presenting
characteristic severe symptoms of the golden mosaic
disease.
In 2011, a transgenic bean event (named EMB-PV051-1;
Embrapa 5.1) resistant to the BGMV was approved for
cultivation and consumption in Brazil. Biosafety evalua-
tions were carried out taking into account the protocol
proposed by the Brazilian Biosafety Committee (CTNBio)
to demonstrate the safety of transgenic bean event to the
environment and human health. Analyses have suggested
no differences between the transgenic event and its non-
transgenic counterpart.
Published: 1 October 2014
References
1. Aragão FJ, Faria JC: First transgenic geminivirus-resistant plant in the
field. Nature Biotechnology 2009, 27(12):1086-1088.
2. Baulcombe D: RNA silencing. Trends Biochem Sci 2005, 30:290-293.
3. Waterhouse PM, Wang MB, Lough T: Gene silencing as an adaptive
defence against viruses. Nature 2001, 411(6839):834-842.
4. Bonfim K, Faria JC, Nogueira EOPL, Mendes EA, Aragão JFJL: RNAi-Mediated
Resistance to Bean golden mosaic virus in Genetically Engineered
Common Bean (Phaseolus vulgaris). MolPlant-Microbe Interact 2007,
20(6):717-726.
doi:10.1186/1753-6561-8-S4-O24
Cite this article as: Lima Aragão: GM plants with RNAi - golden mosaic
resistant bean. BMC Proceedings 2014 8(Suppl 4):O24.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lima Aragão BMC Proceedings 2014, 8(Suppl 4):O24
http://www.biomedcentral.com/1753-6561/8/S4/O24
Page 2 of 2
